Use of Rituximab in the treatment of extensive chronic graft versus host disease after allogenic stem cells transplantation.
Phase of Trial: Phase II
Latest Information Update: 29 Jul 2011
At a glance
- Drugs Rituximab (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 29 Jul 2011 New trial record